CDW Corp Finalizes Proxy Materials for Annual Meeting, Including Key Governance Votes
Summary
CDW Corp has filed definitive additional proxy materials, setting the stage for its Annual Meeting on May 21, 2026, where shareholders will vote on significant corporate governance proposals, including permitting stockholder action by written consent.
Key Events
-
Finalizes Annual Meeting Details
CDW Corp has filed definitive additional proxy materials, confirming the Annual Meeting date as May 21, 2026, and providing final voting instructions for shareholders.
-
Vote on Stockholder Action by Written Consent
Shareholders will vote on an amendment to the Certificate of Incorporation to permit stockholder action by written consent, a significant governance change that the Board recommends 'For'.
-
Stockholder Proposal for Independent Board Chair
A stockholder proposal regarding independent Board chair requirements will be presented for a vote, with the Board recommending 'Against' this proposal.
-
Routine Proxy Items
The proxy materials also include routine votes on the advisory approval of named executive officer compensation and the ratification of Ernst & Young LLP as the independent registered public accounting firm.
Analysis
This DEFA14A filing provides the definitive details and voting instructions for CDW Corp's upcoming Annual Meeting on May 21, 2026. It follows the preliminary proxy statement filed on March 27, 2026, which initially outlined these proposals. The most significant items for shareholders are the vote on amending the Certificate of Incorporation to permit stockholder action by written consent, which the Board supports, and a stockholder proposal regarding an independent Board chair, which the Board opposes. These governance items could impact shareholder influence and corporate oversight. Investors should review the definitive materials to understand the full implications of these votes.
At the time of this filing, CDW was trading at $126.75 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $16.3B. The 52-week trading range was $112.98 to $192.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.